HAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award

Ochre Bio Signs $1 B Deal with Boehringer Ingelheim to Develop Liver Disease Drugs

Aeovian Pharmaceuticals Closes $50 Million Follow-On Round and Moves Towards Human Clinical Trials

Auron Selects First Development Candidate from its Novel AURIGIN™ Platform

HAYA Therapeutics wins the top prize at the TOP 100 Swiss Startup Award 2023

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial of BL-001, a Potential First-in-Class Therapeutic Being Developed for Both Dravet Syndrome and ALS

Auron Establishes Premier Scientific Advisory Board to Support the Advancement of its AI-Powered Platform and Pipeline Targeting Cellular Plasticity in Cancer

Focal Biosciences: new cellular reprogramming startup unveiled